Professionally Cannabis & Psychedelics

For Part 1 of this episode we are joined by Veronika Gold, Co-Founder & Psychotherapist at Polaris Insight Center – innovators within the psychedelics therapy field. As a MAPS-Trained clinician and someone with reams of experience in psychotherapy, Veronika is the perfect person to discuss the therapeutic potential of expanded states of consciousness, with a particular focus on ketamine-assisted therapy and unlocking the potential of MDMA. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

For this episode we welcome back to the podcast Dr. David (Dedi) Meiri, a world-renowned cannabis researcher from the Technion - Israel Institute of Technology. With over 90 scientists working alongside Dedi on a variety of research projects at the Technion and CannaSoul, Dedi and his team tackle many of the world’s most significant illnesses and conditions, including – but not limited to – cancer, inflammatory bowel disease, epilepsy and Alzheimer’s. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

For today’s episode we’re joined by Cosmo Feilding Mellen, CEO of Beckley Psytech. Born out of the Beckley Foundation – a world-renowned organisation who have been central to drug policy reform and research into psychoactive substances for over two decades – Cosmo and his team are at the forefront of modern-day psychedelic science. With clinical trials currently in play and a bulging war chest following an oversubscribed Series B funding round, tune in to hear what’s being cooked up at Beckley HQ and more. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Joining the Professionally Cannabis Podcast to discuss everything cannabis education is Max Simon, the Co-Founder and CEO of Green Flower (a cannabis education platform working alongside businesses and universities) and Ganjier (a cannabis sommelier certification course for plant professionals). Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Joining the podcast for today’s episode is Nick Murray, Co-Founder and CEO of Wake Network – a psychedelic start-up looking to leverage the far-ranging benefits of magic mushrooms for health and wellbeing. Amidst the psychedelic renaissance we find ourselves in, tune in to hear Nick discussing what it’s been like navigating business growth in the psychedelic space, and talking through the specific benefits of natural psychedelic compounds, derived from magic mushrooms. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Today’s episode will be slightly different to the norm… Having received a few notes from newer listeners keen to understand more about individual cannabinoids, I thought it would be cool this week to play out a session that ran last year at the GCI Summit with none other than Dr. Ethan Russo. As one of the modern-day OGs of cannabis research and science, it is always a pleasure to pick the brain of Ethan, who is an unequivocal authority on the plant and its constituent parts. As a heads up, the session was initially recorded on Zoom, so the audio quality will be slightly different to the typical pods; however, I hope that hearing the wonderful insights of Dr. Russo will be enough of an audio feast for you! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

For this week’s episode, Tim Schlidt, Co-Founder and Partner at psychedelics VC firm, Palo Santo joined the pod in conversation. The psychedelics industry has experienced growth at breakneck speed over the past two years, with swathes of ground-breaking research and cutting-edge companies looking to revolutionise mental health treatment as we know it. With over 20 companies across their portfolio of Psychedelic Pioneers, there’s no doubt that Tim has much to share on the latest innovations in the space, and the type of companies that are driving these forwards. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

For this week’s episode, we talk cannabis in Germany with Niklas Kouparanis, the Co-Founder & CEO of Bloomwell Group. With the biggest medical cannabis market in Europe and imminent plans to pass new laws permitting recreational use of the plant, Nik joins us to discuss the practicalities, time lines and critical success factors for Germany, as adult-use cannabis in the country has moved from an ‘if’ to a ‘when’. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Tune into today’s podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health. Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical trials (alongside the University of California, San Francisco), registering a whole host of IP and making strides forward within drug discovery. As a company that favours naturally derived psychedelics, rather than their synthetic counterparts, this is a must listen for anyone with a keen eye on psychedelic medicine! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Earlier this year, I was joined by one of the most recognisable names for folks who operate on the business side of the cannabis industry - Terry Booth, the CEO of Audacious and Former CEO and Founder of Aurora Cannabis. Having developed one of the largest cannabis companies worldwide, followed by leading further investments and ventures in the space, Terry is as candid and energetic as ever over our conversation! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

The pod returns (following a short holiday and a longer illness!) with a conversation I had earlier this year with Zoe Helene, the Founder and Chief Visionary Officer of Cosmic Sister. Zoe takes us on a psychedelic journey that kicked off in the 90s and delves into a range of topics, including Psychedelic Feminism. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

Joining the pod is Nancy Whiteman, Co-Founder & CEO of Wana Brands, one of the leading names in cannabis retail. Most well known for their gummies, Wana have blazed a trail for cannabis brands across the U.S. and recently were subject to a $300m acquisition by Canopy Growth. Nancy is an inspirational cannabis exec and someone who was more than happy to share the experience and expertise needed to build this behemoth of cannabis retail!

As the lead investor in Compass Pathways, Founder of Atai Life Sciences and Apeiron Investment Group, Christian is the perfect person to talk everything psychedelics in 2022. With a diverse portfolio across Fintech, Crypto, Life Sciences, Media, Entertainment and more, Christian is a true leader in spotting unique business opportunities and driving these organisations forward. Tune into Christian's interview today! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

The Professionally Cannabis Podcast returns for 2022, with Andreas Neumann, Chief Creative Officer at Jushi taking the hotseat for the first ep of the year! Across 3 decades Dre has had a fascinating career, working with the likes of Iggy Pop, the Foo Fighters, and even Pele across a plethora of different roles within business, entertainment, photography and more! Since joining Jushi, he has revolutionised their retail footprint, making the organisation one of the hottest MSOs in the industry. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

Joining the pod today is Dr. Jeffrey Becker – a psychiatrist and the Co-Founder & Chief Scientific Officer of Bexson Biomedical. Over the conversation, Jeffrey takes us on his journey to psychedelics, finding himself as a mystic and delving into the interconnectivity of consciousness, ego and self within the healing process. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

For this week’s episode, Jon Sandelman, the CEO of Ayr Wellness, joined the pod for an access-all-areas interview. Over the conversation, Jon takes us on his journey into cannabis, delving into how he set up a listed fund in Canada for US plant touching businesses, selecting companies for acquisition and setting a company culture across a diverse group of organisations. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

Joining the pod this week is Jim Hourigan, the CEO of leading California cannabis brandhouse, CannaCraft. Known for popular brands, such as Absolute Xtracts and Care by Design, Jim talks us through the growing popularity of the cannabis beverage sector, with CannaCraft’s beer developed alongside Lagunitas (of Heineken fame), techniques for growing quality and consistent sun grown cannabis, and best practice for responding to growing consumer demand. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

Want to know more about medical research on Ayahuasca? Tune into our conversation with Dr, Simon Ruffell and WaiFung Tsang of the Psychae Institute at University of Melbourne & Kings College London, respectively. Simon and WaiFung talk us through their journey to psychedelics – from self-funding an observational study around ayahuasca, through to receiving funding from the UK government to further their fantastic research! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

Earlier this year, we caught up with Josh Kirby, the Co-Founder & CEO of Kin Slips – a California-based brand looking to redefine cannabis delivery mechanisms through their sublingual strips. Josh takes us on his journey from making brownies at university to designing innovative products for the California cannabis market, including some M&A along the way. Check out Josh’s interview today! Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

Tune into this week’s pod with one of the OGs of cannabis research - Professor Roger Pertwee, Emeritus Professor at the University of Aberdeen. In no uncertain terms, across over 50 years of cannabis research, Roger is behind many of the scientific breakthroughs that underpin our understanding of the pharmacology of cannabis and the endocannabinoid system. Having collaborated with Dr. Raphael Mechoulam in the early days of cannabis research, Roger is a true legend with an amazing story. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/